Beclamide

A drug used in the treatment of epilepsy

Beclamide
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Beclamide is a medication primarily used in the treatment of epilepsy. It is classified as an anticonvulsant and works by stabilizing the electrical activity in the brain. Beclamide is particularly effective in managing generalized tonic-clonic seizures and partial seizures.

Pharmacology

Beclamide functions by modulating the activity of neurotransmitters in the brain, which helps to prevent the abnormal electrical discharges that lead to seizures. The exact mechanism of action is not fully understood, but it is believed to involve the enhancement of GABAergic inhibition and the reduction of glutamatergic excitation.

Chemical Properties

Structural formula of Beclamide

Beclamide is chemically known as 3-chloro-N-ethyl-N-phenylpropanamide. It is a white crystalline powder that is soluble in water and alcohol. The molecular formula is C₁₁H₁₄ClNO, and it has a molecular weight of 211.69 g/mol.

Clinical Use

Beclamide is used in the management of epilepsy, particularly in patients who experience generalized tonic-clonic and partial seizures. It is often prescribed when other anticonvulsants are not effective or cause undesirable side effects. The dosage of beclamide is tailored to the individual needs of the patient, and it is usually administered orally.

Side Effects

Common side effects of beclamide include drowsiness, dizziness, and gastrointestinal disturbances such as nausea and vomiting. In some cases, patients may experience allergic reactions, skin rashes, or blood dyscrasias. It is important for patients to be monitored regularly by their healthcare provider while taking beclamide.

History

Beclamide was first introduced in the mid-20th century as an anticonvulsant. It has been used in various countries for the treatment of epilepsy, although its use has declined with the development of newer anticonvulsants that have more favorable side effect profiles.

Related pages

• Epilepsy
• Anticonvulsant
• Generalized tonic-clonic seizure
• Partial seizure